Early transplant related mortality in lymphoma patients undergoing autologous hematopoietic stem cell transplantation after conditioning with CBV (cyclophosphamide, carmustine and etoposide)

被引：0
|
作者：
Regadera, A
Jarque, I
de la Rubia, J
Andreu, R
Garcia, I
Moscardó, F
Mena, A
Yuste, A
Jimenez, C
Martín, G
Martínez, J
Sanz, G
Saavedra, S
Mollá, S
Plumé, G
Sanz, MA
机构：
来源：
BONE MARROW TRANSPLANTATION | 2001年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S264 / S264
页数：1
相关论文
共 50 条
  • [41] Transplant related mortality in older adults undergoing autologous stem cell transplantation.
    Klepin, HD
    Harish, V
    Keung, Y
    Hurd, D
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (04) : S152 - S152
  • [42] Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients
    Leal, Christianne Toledo de Souza
    Costa, Luciano Jose Megale
    Pereira, Juliana
    Duarte, Fernando Barroso
    Tavares, Raphael Barros
    Atalla, Angelo
    Sabioni, Bruna Sousa
    Neto, Abrahao Elias Hallack
    BONE MARROW TRANSPLANTATION, 2022, 57 (02) : 309 - 311
  • [43] Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients
    Christianne Tolêdo de Souza Leal
    Luciano José Megale Costa
    Juliana Pereira
    Fernando Barroso Duarte
    Raphael Barros Tavares
    Angelo Atalla
    Bruna Sousa Sabioni
    Abrahão Elias Hallack Neto
    Bone Marrow Transplantation, 2022, 57 : 309 - 311
  • [44] Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin’s disease
    DE Reece
    TJ Nevill
    A Sayegh
    JJ Spinelli
    DA Brockington
    MJ Barnett
    H-G Klingemann
    JM Connors
    SH Nantel
    JD Shepherd
    HJ Sutherland
    NJS Voss
    RN Fairey
    SE O’Reilly
    GL Phillips
    Bone Marrow Transplantation, 1999, 23 : 1131 - 1138
  • [45] Phase II Study of Propylene Glycol-Free Melphalan (Evomela) Combined with Carmustine, Etoposide, and Cytarabine (BEAM) for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
    Cashen, Amanda F.
    Gosch, Kendall
    Fletcher, Theresa
    Ceriotti, Connie
    Ghobadi, Armin
    Vij, Ravi
    Stocker-Goldstein, Keith
    Dipersio, John F.
    Abboud, Camille N.
    BLOOD, 2015, 126 (23)
  • [46] Conditioning regimen intensity and transplant related mortality in patients treated for autoimmune diseases by autologous stem cell transplantation
    Kashyap, J
    Passweg, J
    Fassas, A
    Gratwohl, A
    Tyndall, A
    BONE MARROW TRANSPLANTATION, 2001, 27 : S4 - S4
  • [47] ESCALATING DOSE OF MITOXANTRONE WITH HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE IN PATIENTS WITH REFRACTORY LYMPHOMA UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    ATTAL, M
    CANAL, P
    SCHLAIFER, D
    CHATELUT, E
    DEZEUZE, A
    HUGUET, F
    PAYEN, C
    PRIS, J
    LAURENT, G
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (01) : 141 - 148
  • [48] ESCALATING DOSE OF MITOXANTRONE WITH HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE IN REFRACTORY LYMPHOMA PATIENTS UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    SCHLAIFER, D
    ATTAL, M
    HUGUET, F
    CANAL, P
    LAURENT, G
    PRIS, J
    SEMINARS IN HEMATOLOGY, 1994, 31 (02) : 31 - 31
  • [49] Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients
    Akhtari, Mojtaba
    Bhatt, Vijaya Raj
    Tandra, Pavan Kumar
    Krishnamurthy, Jairam
    Horstman, Heidi
    Dreessen, Amy
    Chen, Pei Xian
    Armitage, James O.
    CANCER BIOLOGY & THERAPY, 2013, 14 (12) : 1077 - 1088
  • [50] BeEAC conditioning regimen for autologous hematopoietic stem-cell transplantation in malignant lymphoma patients
    Dubinina, Yulia
    Sarzhevskiy, Vladislav
    Samoylova, Anastasiya
    Mochkin, Nikita
    Melnichenko, Vladimir
    Kolesnikova, Dina
    Bogatyrev, Vladimir
    Smirnova, Elena
    Ivanova, Diana
    Bannikova, Anna
    BONE MARROW TRANSPLANTATION, 2018, 53 : 260 - 261
12345